Mindray Medical will vote for shareholder privatization of $3.3 billion
Shareholders of China's medical device giant Mindray Medical (NYSE: MR) are scheduled to meet next month to vote on a $3.3 billion privatization plan, and the company's digital executives are the initiators of privatization. Mindray Medical, headquartered in Shenzhen, said the transaction value was $28 per share and the vote was scheduled for February 26. In June last year, Mindray’s two co-CEOs, Li Xiting and Cheng Minghe and Mind Chairman Xu Hang, had offered $30 per share for a total price of $3.5 billion to privatize Mindray. After that, the three men lowered their offer to $27 per share for a total of $3.15 billion. In November last year, the parties finally agreed to set the price at 28 US dollars per share. Li Xiting, Cheng Minghe and Xu Hang and the entities they control have combined to control Mindray's total voting rights of 63.7%. Notebook Ultrasound Scanner,B W Ultrasound Machine,Ultrasound Bone Densitometer,Ultrasound Machine Instrument Mianyang United Ultrasound Electronics Co., Ltd , https://www.uniultrasonic.com